☰

Nichole M. Neugebauer - Publications

Affiliations: 
Yale University, New Haven, CT 
Area:
Behavioral Pharmacology, Drug Abuse
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Mascia P, Neugebauer NM, Brown J, Bubula N, Nesbitt KM, Kennedy RT, Vezina P. Exposure to conditions of uncertainty promotes the pursuit of amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29875447 DOI: 10.1038/S41386-018-0099-4  0.451
2017 Neugebauer NM, Miyauchi M, Sato T, Tadano J, Akal H, Ardehali H, Meltzer HY. Hippocampal GABAA antagonism reverses the novel object recognition deficit in sub-chronic phencyclidine-treated rats. Behavioural Brain Research. PMID 29289597 DOI: 10.1016/J.Bbr.2017.12.033  0.306
2017 Miyauchi M, Neugebauer NM, Sato T, Ardehali H, Meltzer HY. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats. Journal of Psychopharmacology (Oxford, England). 269881117731278. PMID 28946779 DOI: 10.1177/0269881117731278  0.34
2017 Rodríguez G, Neugebauer NM, Yao KL, Meltzer HY, Csernansky JG, Dong H. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice. Pharmacology, Biochemistry, and Behavior. PMID 28648819 DOI: 10.1016/J.Pbb.2017.06.010  0.328
2017 Miyauchi M, Neugebauer NM, Meltzer HY. Dopamine D4 receptor stimulation contributes to novel object recognition: Relevance to cognitive impairment in schizophrenia. Journal of Psychopharmacology (Oxford, England). 31: 442-452. PMID 28347261 DOI: 10.1177/0269881117693746  0.341
2015 Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY. Nicotinic receptors and lurasidone-mediated reversal of phencyclidine-induced deficit in novel object recognition. Behavioural Brain Research. PMID 26519556 DOI: 10.1016/J.Bbr.2015.10.044  0.445
2015 Horiguchi M, Miyauchi M, Neugebauer NM, Oyamada Y, Meltzer HY. Prolonged reversal of the phencyclidine-induced impairment in novel object recognition by a serotonin (5-HT)1A-dependent mechanism. Behavioural Brain Research. PMID 26342283 DOI: 10.1016/J.Bbr.2015.08.040  0.393
2014 Singer BF, Neugebauer NM, Forneris J, Rodvelt KR, Li D, Bubula N, Vezina P. Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 85: 243-52. PMID 24939858 DOI: 10.1016/J.Neuropharm.2014.05.033  0.388
2014 Neugebauer NM, Cortright JJ, Sampedro GR, Vezina P. Exposure to nicotine enhances its subsequent self-administration: contribution of nicotine-associated contextual stimuli. Behavioural Brain Research. 260: 155-61. PMID 24295728 DOI: 10.1016/J.Bbr.2013.11.035  0.555
2013 Meyer AC, Neugebauer NM, Zheng G, Crooks PA, Dwoskin LP, Bardo MT. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of Neurochemistry. 127: 187-98. PMID 23875705 DOI: 10.1111/Jnc.12373  0.688
2013 Wickham RJ, Solecki W, Rathbun LR, Neugebauer NM, Wightman RM, Addy NA. Advances in studying phasic dopamine signaling in brain reward mechanisms. Frontiers in Bioscience (Elite Edition). 5: 982-99. PMID 23747914 DOI: 10.2741/E678  0.666
2013 Neugebauer NM, Einstein EB, Lopez MB, McClure-Begley TD, Mineur YS, Picciotto MR. Morphine dependence and withdrawal induced changes in cholinergic signaling. Pharmacology, Biochemistry, and Behavior. 109: 77-83. PMID 23651795 DOI: 10.1016/J.Pbb.2013.04.015  0.775
2013 Giza JI, Jung Y, Jeffrey RA, Neugebauer NM, Picciotto MR, Biederer T. The synaptic adhesion molecule SynCAM 1 contributes to cocaine effects on synapse structure and psychostimulant behavior. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 628-38. PMID 23169347 DOI: 10.1038/Npp.2012.226  0.747
2012 Berry JN, Neugebauer NM, Bardo MT. Reinstatement of methamphetamine conditioned place preference in nicotine-sensitized rats. Behavioural Brain Research. 235: 158-65. PMID 22884606 DOI: 10.1016/J.Bbr.2012.07.043  0.665
2012 Cortright JJ, Sampedro GR, Neugebauer NM, Vezina P. Previous exposure to nicotine enhances the incentive motivational effects of amphetamine via nicotine-associated contextual stimuli. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2277-84. PMID 22617358 DOI: 10.1038/Npp.2012.80  0.581
2012 Horst NK, Heath CJ, Neugebauer NM, Kimchi EY, Laubach M, Picciotto MR. Impaired auditory discrimination learning following perinatal nicotine exposure or β2 nicotinic acetylcholine receptor subunit deletion. Behavioural Brain Research. 231: 170-80. PMID 22433585 DOI: 10.1016/J.Bbr.2012.03.002  0.75
2011 Meyer AC, Horton DB, Neugebauer NM, Wooters TE, Nickell JR, Dwoskin LP, Bardo MT. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology. 61: 849-56. PMID 21669212 DOI: 10.1016/J.Neuropharm.2011.05.033  0.768
2011 Neugebauer NM, Henehan RM, Hales CA, Picciotto MR. Mice lacking the galanin gene show decreased sensitivity to nicotine conditioned place preference. Pharmacology, Biochemistry, and Behavior. 98: 87-93. PMID 21172385 DOI: 10.1016/J.Pbb.2010.12.015  0.653
2010 Stairs DJ, Neugebauer NM, Bardo MT. Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats. Behavioural Pharmacology. 21: 182-93. PMID 20440201 DOI: 10.1097/Fbp.0B013E32833A5C9E  0.806
2010 Neugebauer NM, Harrod SB, Bardo MT. Nicotine elicits methamphetamine-seeking in rats previously administered nicotine. Drug and Alcohol Dependence. 106: 72-8. PMID 19733448 DOI: 10.1016/J.Drugalcdep.2009.07.018  0.714
2010 Picciotto MR, Brabant C, Einstein EB, Kamens HM, Neugebauer NM. Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Research. 1314: 206-18. PMID 19699187 DOI: 10.1016/J.Brainres.2009.08.033  0.724
2009 Dwoskin LP, Pivavarchyk M, Joyce BM, Neugebauer NM, Zheng G, Zhang Z, Bardo MT, Crooks PA. Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium On Motivation. Nebraska Symposium On Motivation. 55: 31-63. PMID 19013938 DOI: 10.1007/978-0-387-78748-0_4  0.616
2008 Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens. European Journal of Pharmacology. 601: 103-5. PMID 19000671 DOI: 10.1016/J.Ejphar.2008.10.037  0.677
2008 Wooters TE, Neugebauer NM, Rush CR, Bardo MT. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1137-48. PMID 17581534 DOI: 10.1038/Sj.Npp.1301477  0.811
2007 Dwoskin LP, Joyce BM, Zheng G, Neugebauer NM, Manda VK, Lockman P, Papke RL, Bardo MT, Crooks PA. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology. 74: 1271-82. PMID 17727820 DOI: 10.1016/J.Bcp.2007.07.021  0.668
2007 Neugebauer NM, Harrod SB, Stairs DJ, Crooks PA, Dwoskin LP, Bardo MT. Lobelane decreases methamphetamine self-administration in rats. European Journal of Pharmacology. 571: 33-8. PMID 17612524 DOI: 10.1016/J.Ejphar.2007.06.003  0.786
2007 Rahman S, Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens. Neuropharmacology. 52: 755-63. PMID 17097117 DOI: 10.1016/J.Neuropharm.2006.09.012  0.704
2007 Stairs DJ, Neugebauer NM, Wei X, Boustany C, Hojahmat M, Cassis LA, Crooks PA, Dwoskin LP, Bardo MT. Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats. Psychopharmacology. 190: 145-55. PMID 17096082 DOI: 10.1007/S00213-006-0610-1  0.786
2006 Neugebauer NM, Zhang Z, Crooks PA, Dwoskin LP, Bardo MT. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats. Psychopharmacology. 184: 426-34. PMID 16220336 DOI: 10.1007/S00213-005-0163-8  0.708
2005 Neugebauer N, Harrod S, Bardo M. B38 THE EFFECT OF NICOTINE PRETREATMENT ON METHAMPHETAMINE SELF-ADMINISTRATION, METHAMPHETAMINE-SEEKING, AND LOCOMOTOR ACTIVITY IN RATS Behavioural Pharmacology. 16: S77-S78. DOI: 10.1097/00008877-200509001-00243  0.669
2004 Neugebauer NM, Cunningham ST, Zhu J, Bryant RI, Middleton LS, Dwoskin LP. Effects of environmental enrichment on behavior and dopamine transporter function in medial prefrontal cortex in adult rats prenatally treated with cocaine. Brain Research. Developmental Brain Research. 153: 213-23. PMID 15527889 DOI: 10.1016/J.Devbrainres.2004.09.001  0.397
2003 Rauhut AS, Neugebauer N, Dwoskin LP, Bardo MT. Effect of bupropion on nicotine self-administration in rats. Psychopharmacology. 169: 1-9. PMID 12811464 DOI: 10.1007/S00213-003-1450-X  0.69
Show low-probability matches.